Michael Zuscik
Concepts (550)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis | 27 | 2025 | 185 | 5.840 |
Why?
| | Chondrocytes | 46 | 2025 | 212 | 3.940 |
Why?
| | Cartilage, Articular | 19 | 2025 | 311 | 2.390 |
Why?
| | Transforming Growth Factor beta | 23 | 2014 | 480 | 1.760 |
Why?
| | Chondrogenesis | 10 | 2016 | 83 | 1.290 |
Why?
| | Joints | 4 | 2025 | 105 | 1.270 |
Why?
| | Gastrointestinal Microbiome | 3 | 2025 | 697 | 1.230 |
Why?
| | Fracture Healing | 6 | 2014 | 79 | 1.140 |
Why?
| | Menisci, Tibial | 3 | 2021 | 61 | 1.120 |
Why?
| | Cell Differentiation | 33 | 2018 | 1991 | 1.070 |
Why?
| | Osteoarthritis, Knee | 6 | 2023 | 254 | 1.000 |
Why?
| | Bone Morphogenetic Proteins | 15 | 2008 | 135 | 0.960 |
Why?
| | Growth Plate | 8 | 2013 | 36 | 0.930 |
Why?
| | Cartilage | 12 | 2021 | 188 | 0.820 |
Why?
| | Lead | 6 | 2014 | 64 | 0.810 |
Why?
| | Animals | 102 | 2025 | 36940 | 0.800 |
Why?
| | Mice | 66 | 2025 | 17787 | 0.790 |
Why?
| | Osteogenesis | 13 | 2018 | 188 | 0.760 |
Why?
| | Obesity | 10 | 2018 | 2992 | 0.740 |
Why?
| | Disease Models, Animal | 18 | 2021 | 4295 | 0.740 |
Why?
| | Receptors, Adrenergic, alpha-1 | 8 | 2003 | 45 | 0.700 |
Why?
| | Dysbiosis | 2 | 2020 | 181 | 0.700 |
Why?
| | Joint Diseases | 1 | 2021 | 60 | 0.700 |
Why?
| | Diet, High-Fat | 6 | 2018 | 247 | 0.680 |
Why?
| | Wounds and Injuries | 3 | 2019 | 758 | 0.680 |
Why?
| | Knee Injuries | 2 | 2021 | 99 | 0.670 |
Why?
| | Inflammation | 5 | 2020 | 2837 | 0.650 |
Why?
| | Signal Transduction | 34 | 2021 | 5079 | 0.650 |
Why?
| | Mice, Inbred C57BL | 27 | 2025 | 5757 | 0.640 |
Why?
| | Smad3 Protein | 6 | 2012 | 43 | 0.630 |
Why?
| | beta Catenin | 11 | 2016 | 253 | 0.610 |
Why?
| | Collagen Type I | 2 | 2017 | 136 | 0.530 |
Why?
| | Dietary Supplements | 2 | 2021 | 561 | 0.530 |
Why?
| | Microbiota | 1 | 2025 | 762 | 0.530 |
Why?
| | Cells, Cultured | 31 | 2018 | 4193 | 0.520 |
Why?
| | Bony Callus | 3 | 2014 | 5 | 0.490 |
Why?
| | Bone Morphogenetic Protein 2 | 15 | 2014 | 66 | 0.490 |
Why?
| | Diabetes Mellitus, Type 2 | 8 | 2018 | 2531 | 0.470 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 8 | 2019 | 40 | 0.470 |
Why?
| | Teriparatide | 2 | 2011 | 7 | 0.460 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 6 | 2009 | 136 | 0.430 |
Why?
| | NF-kappa B | 5 | 2021 | 691 | 0.430 |
Why?
| | Synovial Membrane | 4 | 2025 | 117 | 0.420 |
Why?
| | Dinoprostone | 5 | 2009 | 191 | 0.420 |
Why?
| | Erythropoietin | 2 | 2017 | 95 | 0.400 |
Why?
| | Neuroprotective Agents | 2 | 2016 | 131 | 0.390 |
Why?
| | Collagen Type X | 11 | 2012 | 14 | 0.390 |
Why?
| | Osteoclasts | 7 | 2015 | 52 | 0.390 |
Why?
| | Staphylococcal Infections | 4 | 2018 | 400 | 0.380 |
Why?
| | Benzo(a)pyrene | 1 | 2012 | 8 | 0.380 |
Why?
| | Receptors, Aryl Hydrocarbon | 2 | 2012 | 55 | 0.380 |
Why?
| | X-Ray Microtomography | 9 | 2016 | 94 | 0.380 |
Why?
| | Receptors, Notch | 4 | 2015 | 88 | 0.380 |
Why?
| | Trans-Activators | 11 | 2005 | 398 | 0.380 |
Why?
| | Hindlimb | 2 | 2011 | 128 | 0.380 |
Why?
| | Gene Expression Regulation | 15 | 2017 | 2607 | 0.370 |
Why?
| | Collateral Ligaments | 1 | 2011 | 16 | 0.370 |
Why?
| | Chickens | 13 | 2012 | 191 | 0.370 |
Why?
| | Knee Joint | 4 | 2021 | 409 | 0.340 |
Why?
| | Disease Progression | 9 | 2021 | 2757 | 0.340 |
Why?
| | Ubiquitin-Protein Ligases | 6 | 2010 | 175 | 0.330 |
Why?
| | Receptors, Adrenergic | 2 | 2000 | 33 | 0.320 |
Why?
| | Sciatic Nerve | 2 | 2017 | 58 | 0.320 |
Why?
| | Gene Library | 2 | 2000 | 118 | 0.320 |
Why?
| | Sciatic Neuropathy | 3 | 2019 | 29 | 0.320 |
Why?
| | Regeneration | 1 | 2011 | 197 | 0.320 |
Why?
| | Parathyroid Hormone | 3 | 2013 | 108 | 0.310 |
Why?
| | Chick Embryo | 11 | 2012 | 130 | 0.310 |
Why?
| | Adiposity | 1 | 2014 | 518 | 0.310 |
Why?
| | Tobacco Smoke Pollution | 1 | 2012 | 261 | 0.310 |
Why?
| | Mice, Transgenic | 19 | 2015 | 2167 | 0.300 |
Why?
| | Transcription Factor AP-1 | 3 | 2007 | 92 | 0.300 |
Why?
| | Proto-Oncogene Proteins | 1 | 2012 | 648 | 0.300 |
Why?
| | Immunoglobulin J Recombination Signal Sequence-Binding Protein | 3 | 2013 | 6 | 0.290 |
Why?
| | 4-Aminopyridine | 2 | 2019 | 24 | 0.290 |
Why?
| | Potassium Channel Blockers | 2 | 2019 | 37 | 0.290 |
Why?
| | Cell Cycle Proteins | 4 | 2014 | 617 | 0.280 |
Why?
| | Osteoblasts | 7 | 2015 | 126 | 0.280 |
Why?
| | Bone and Bones | 6 | 2015 | 317 | 0.280 |
Why?
| | Regenerative Medicine | 2 | 2022 | 49 | 0.270 |
Why?
| | Receptors, Prostaglandin E | 3 | 2009 | 7 | 0.270 |
Why?
| | Promoter Regions, Genetic | 8 | 2013 | 1250 | 0.250 |
Why?
| | Lymphatic Vessels | 2 | 2019 | 64 | 0.250 |
Why?
| | Parathyroid Hormone-Related Protein | 7 | 2005 | 24 | 0.250 |
Why?
| | Synbiotics | 1 | 2025 | 2 | 0.240 |
Why?
| | Gene Expression Regulation, Developmental | 9 | 2015 | 860 | 0.240 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2025 | 42 | 0.240 |
Why?
| | Severity of Illness Index | 3 | 2017 | 2828 | 0.230 |
Why?
| | Neovascularization, Physiologic | 4 | 2014 | 179 | 0.230 |
Why?
| | Sulfonamides | 2 | 2002 | 513 | 0.230 |
Why?
| | Up-Regulation | 6 | 2017 | 843 | 0.230 |
Why?
| | Meniscus | 2 | 2023 | 22 | 0.230 |
Why?
| | Calcium | 7 | 2002 | 1199 | 0.230 |
Why?
| | Phosphatidylinositols | 2 | 1994 | 57 | 0.220 |
Why?
| | Bone Development | 4 | 2011 | 54 | 0.220 |
Why?
| | Proteins | 4 | 2003 | 1009 | 0.220 |
Why?
| | GTPase-Activating Proteins | 3 | 2014 | 83 | 0.220 |
Why?
| | Ankle Joint | 1 | 2025 | 114 | 0.220 |
Why?
| | Transcription Factors | 7 | 2008 | 1719 | 0.210 |
Why?
| | Limb Buds | 5 | 2010 | 23 | 0.210 |
Why?
| | Ligases | 1 | 2003 | 32 | 0.210 |
Why?
| | Calcium Signaling | 2 | 2002 | 249 | 0.210 |
Why?
| | Cardiomegaly | 2 | 2003 | 175 | 0.200 |
Why?
| | Bone Density | 4 | 2025 | 489 | 0.200 |
Why?
| | Arthritis, Experimental | 2 | 2015 | 147 | 0.200 |
Why?
| | Azacitidine | 1 | 2004 | 140 | 0.200 |
Why?
| | Homeostasis | 2 | 2025 | 621 | 0.200 |
Why?
| | Smad Proteins | 6 | 2014 | 42 | 0.200 |
Why?
| | Humans | 35 | 2025 | 137585 | 0.200 |
Why?
| | Peptide Hormones | 1 | 2002 | 11 | 0.200 |
Why?
| | Egtazic Acid | 1 | 2002 | 40 | 0.200 |
Why?
| | Wnt Proteins | 4 | 2014 | 133 | 0.200 |
Why?
| | Tibial Fractures | 2 | 2014 | 68 | 0.190 |
Why?
| | Male | 23 | 2025 | 67762 | 0.190 |
Why?
| | DNA-Binding Proteins | 7 | 2004 | 1502 | 0.190 |
Why?
| | Intracellular Fluid | 1 | 2002 | 27 | 0.190 |
Why?
| | Apoptosis | 6 | 2016 | 2553 | 0.190 |
Why?
| | Scleroderma, Systemic | 1 | 2003 | 122 | 0.190 |
Why?
| | Neurodegenerative Diseases | 2 | 2002 | 135 | 0.190 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 5 | 2007 | 145 | 0.190 |
Why?
| | Fatty Acids | 1 | 2025 | 443 | 0.190 |
Why?
| | Macrophages | 3 | 2019 | 1547 | 0.190 |
Why?
| | Femur | 3 | 2013 | 254 | 0.180 |
Why?
| | Proteoglycans | 4 | 2013 | 107 | 0.180 |
Why?
| | Musculoskeletal System | 1 | 2022 | 48 | 0.180 |
Why?
| | Intercellular Signaling Peptides and Proteins | 4 | 2014 | 382 | 0.180 |
Why?
| | SOX9 Transcription Factor | 2 | 2013 | 24 | 0.170 |
Why?
| | Bone Remodeling | 4 | 2014 | 75 | 0.170 |
Why?
| | Calcium Phosphates | 2 | 2010 | 27 | 0.170 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2023 | 159 | 0.170 |
Why?
| | Tissue Engineering | 3 | 2022 | 423 | 0.170 |
Why?
| | Matrix Metalloproteinase 13 | 4 | 2019 | 24 | 0.170 |
Why?
| | Femoral Fractures | 2 | 2012 | 76 | 0.170 |
Why?
| | Cyclic AMP | 5 | 2005 | 234 | 0.170 |
Why?
| | Atrophy | 1 | 2000 | 184 | 0.170 |
Why?
| | Smad1 Protein | 2 | 2011 | 18 | 0.160 |
Why?
| | Hypotension | 1 | 2001 | 122 | 0.160 |
Why?
| | Transcriptome | 3 | 2025 | 971 | 0.160 |
Why?
| | Cyclin D1 | 2 | 2012 | 68 | 0.160 |
Why?
| | Epoetin Alfa | 1 | 2019 | 9 | 0.160 |
Why?
| | Staphylococcus aureus | 3 | 2018 | 450 | 0.150 |
Why?
| | Nerve Compression Syndromes | 1 | 2019 | 21 | 0.150 |
Why?
| | Hematinics | 1 | 2019 | 22 | 0.150 |
Why?
| | Recovery of Function | 2 | 2017 | 653 | 0.150 |
Why?
| | Collagen | 1 | 2021 | 452 | 0.150 |
Why?
| | Bortezomib | 1 | 2019 | 54 | 0.150 |
Why?
| | Proteasome Inhibitors | 1 | 2019 | 46 | 0.150 |
Why?
| | Body Weight | 5 | 2014 | 985 | 0.150 |
Why?
| | Alkaline Phosphatase | 7 | 2011 | 148 | 0.150 |
Why?
| | Bifidobacterium longum | 1 | 2018 | 6 | 0.150 |
Why?
| | Bone Resorption | 3 | 2015 | 86 | 0.140 |
Why?
| | Tissue Scaffolds | 2 | 2010 | 211 | 0.140 |
Why?
| | Immunity, Humoral | 2 | 2018 | 116 | 0.140 |
Why?
| | Organ Size | 2 | 2014 | 477 | 0.140 |
Why?
| | Osteomyelitis | 2 | 2017 | 132 | 0.140 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 1998 | 45 | 0.140 |
Why?
| | Germinal Center | 1 | 2018 | 58 | 0.140 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2023 | 363 | 0.140 |
Why?
| | Osteolysis | 1 | 2018 | 18 | 0.140 |
Why?
| | Oligosaccharides | 1 | 2018 | 60 | 0.140 |
Why?
| | Aging | 3 | 2019 | 1864 | 0.140 |
Why?
| | Coagulase | 1 | 2017 | 6 | 0.140 |
Why?
| | RANK Ligand | 4 | 2015 | 29 | 0.140 |
Why?
| | Foot | 1 | 2018 | 96 | 0.130 |
Why?
| | Transforming Growth Factor beta1 | 4 | 2014 | 165 | 0.130 |
Why?
| | Hydrolysis | 1 | 2017 | 177 | 0.130 |
Why?
| | Prosthesis-Related Infections | 1 | 2018 | 95 | 0.130 |
Why?
| | Polymerase Chain Reaction | 1 | 2000 | 1062 | 0.130 |
Why?
| | Hedgehog Proteins | 5 | 2004 | 195 | 0.130 |
Why?
| | Peripheral Nerve Injuries | 1 | 2016 | 36 | 0.130 |
Why?
| | PPAR gamma | 2 | 2015 | 182 | 0.130 |
Why?
| | Cysteine-Rich Protein 61 | 1 | 2016 | 7 | 0.130 |
Why?
| | Activating Transcription Factor 2 | 3 | 2013 | 5 | 0.130 |
Why?
| | Calcium Channels | 1 | 1997 | 159 | 0.130 |
Why?
| | Glucose Intolerance | 2 | 2015 | 146 | 0.130 |
Why?
| | Osteosarcoma | 2 | 2008 | 74 | 0.130 |
Why?
| | Pain | 1 | 2021 | 756 | 0.120 |
Why?
| | Rotator Cuff Injuries | 1 | 2016 | 60 | 0.120 |
Why?
| | Phenotype | 8 | 2019 | 3196 | 0.120 |
Why?
| | Gene Expression | 4 | 2014 | 1502 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2016 | 1242 | 0.120 |
Why?
| | Receptor, Notch1 | 1 | 2015 | 64 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 8 | 2010 | 976 | 0.120 |
Why?
| | Bone Morphogenetic Protein 6 | 3 | 2004 | 3 | 0.110 |
Why?
| | Administration, Oral | 1 | 2017 | 816 | 0.110 |
Why?
| | Osteocalcin | 2 | 2012 | 37 | 0.110 |
Why?
| | Bone Regeneration | 1 | 2014 | 26 | 0.110 |
Why?
| | Wound Healing | 2 | 2014 | 331 | 0.110 |
Why?
| | Smad2 Protein | 2 | 2012 | 38 | 0.110 |
Why?
| | Collagen Type II | 5 | 2013 | 53 | 0.110 |
Why?
| | Mice, Knockout | 7 | 2014 | 3015 | 0.110 |
Why?
| | Bone Neoplasms | 2 | 2008 | 247 | 0.110 |
Why?
| | Biomechanical Phenomena | 2 | 2014 | 810 | 0.110 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2015 | 195 | 0.100 |
Why?
| | Fractures, Bone | 3 | 2014 | 380 | 0.100 |
Why?
| | Bone Marrow | 1 | 2015 | 286 | 0.100 |
Why?
| | Cell Division | 4 | 2004 | 794 | 0.100 |
Why?
| | Glycogen Synthase Kinase 3 | 2 | 2014 | 82 | 0.100 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2013 | 73 | 0.100 |
Why?
| | Angiopoietin-2 | 1 | 2013 | 16 | 0.100 |
Why?
| | Endothelial Cells | 1 | 2019 | 785 | 0.100 |
Why?
| | Tendon Injuries | 1 | 2014 | 68 | 0.100 |
Why?
| | Phosphoproteins | 2 | 2014 | 338 | 0.100 |
Why?
| | Extracellular Matrix | 3 | 2013 | 528 | 0.100 |
Why?
| | RNA, Messenger | 6 | 2008 | 2833 | 0.100 |
Why?
| | Animals, Newborn | 3 | 2019 | 844 | 0.100 |
Why?
| | Tretinoin | 2 | 2003 | 123 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2018 | 847 | 0.100 |
Why?
| | Bone Transplantation | 1 | 2013 | 90 | 0.100 |
Why?
| | RNA, Small Interfering | 2 | 2012 | 622 | 0.090 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2012 | 33 | 0.090 |
Why?
| | Chelating Agents | 2 | 2002 | 75 | 0.090 |
Why?
| | Base Sequence | 6 | 2013 | 2181 | 0.090 |
Why?
| | Intervertebral Disc Displacement | 1 | 2012 | 40 | 0.090 |
Why?
| | Receptor, Parathyroid Hormone, Type 1 | 1 | 2011 | 3 | 0.090 |
Why?
| | Anabolic Agents | 1 | 2011 | 12 | 0.090 |
Why?
| | Serrate-Jagged Proteins | 1 | 2011 | 27 | 0.090 |
Why?
| | Osteophyte | 1 | 2011 | 6 | 0.090 |
Why?
| | Mast Cells | 1 | 2013 | 147 | 0.090 |
Why?
| | Time Factors | 5 | 2014 | 6828 | 0.090 |
Why?
| | Transcriptional Activation | 3 | 2017 | 378 | 0.090 |
Why?
| | Mice, Inbred Strains | 2 | 2013 | 409 | 0.090 |
Why?
| | Orthopedic Procedures | 1 | 2014 | 216 | 0.090 |
Why?
| | Tibial Meniscus Injuries | 1 | 2011 | 48 | 0.090 |
Why?
| | Arteries | 1 | 2013 | 269 | 0.090 |
Why?
| | Neoplasm Proteins | 2 | 2004 | 434 | 0.090 |
Why?
| | bcl-2-Associated X Protein | 2 | 2008 | 56 | 0.090 |
Why?
| | Analysis of Variance | 2 | 2017 | 1316 | 0.090 |
Why?
| | Bone Substitutes | 1 | 2010 | 28 | 0.090 |
Why?
| | Cyclooxygenase 2 | 2 | 2009 | 178 | 0.090 |
Why?
| | Female | 17 | 2025 | 73304 | 0.080 |
Why?
| | Histone Deacetylases | 1 | 2012 | 215 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2005 | 2057 | 0.080 |
Why?
| | RNA Interference | 1 | 2012 | 469 | 0.080 |
Why?
| | Calcium-Binding Proteins | 1 | 2011 | 218 | 0.080 |
Why?
| | RNA | 1 | 2016 | 921 | 0.080 |
Why?
| | Cytoskeletal Proteins | 2 | 2007 | 158 | 0.080 |
Why?
| | Rats | 9 | 2012 | 5647 | 0.080 |
Why?
| | Dietary Fats | 1 | 2011 | 304 | 0.080 |
Why?
| | Molecular Sequence Data | 5 | 2004 | 2900 | 0.080 |
Why?
| | Stress, Mechanical | 2 | 2010 | 485 | 0.080 |
Why?
| | Osteoporosis | 1 | 2012 | 243 | 0.080 |
Why?
| | Isoquinolines | 2 | 2002 | 43 | 0.080 |
Why?
| | Lactic Acid | 1 | 2010 | 305 | 0.080 |
Why?
| | Blotting, Western | 5 | 2011 | 1226 | 0.080 |
Why?
| | Nerve Crush | 1 | 2008 | 9 | 0.070 |
Why?
| | Cell Survival | 1 | 2012 | 1120 | 0.070 |
Why?
| | Inositol 1,4,5-Trisphosphate | 2 | 2001 | 21 | 0.070 |
Why?
| | Weight Gain | 1 | 2011 | 519 | 0.070 |
Why?
| | Neural Conduction | 2 | 2019 | 86 | 0.070 |
Why?
| | Core Binding Factor Alpha 3 Subunit | 1 | 2007 | 6 | 0.070 |
Why?
| | Immunohistochemistry | 2 | 2010 | 1738 | 0.070 |
Why?
| | Repressor Proteins | 2 | 2008 | 427 | 0.070 |
Why?
| | High Mobility Group Proteins | 1 | 2007 | 44 | 0.070 |
Why?
| | Protein Isoforms | 2 | 2007 | 404 | 0.070 |
Why?
| | Tyrosine | 2 | 2010 | 222 | 0.070 |
Why?
| | Ubiquitin | 2 | 2004 | 70 | 0.070 |
Why?
| | Polymers | 1 | 2010 | 490 | 0.060 |
Why?
| | Biocompatible Materials | 1 | 2010 | 425 | 0.060 |
Why?
| | Cell Membrane | 3 | 2001 | 738 | 0.060 |
Why?
| | Prazosin | 2 | 2002 | 23 | 0.060 |
Why?
| | Smad7 Protein | 1 | 2005 | 19 | 0.060 |
Why?
| | Stem Cells | 3 | 2022 | 594 | 0.060 |
Why?
| | Cell Proliferation | 5 | 2013 | 2475 | 0.060 |
Why?
| | I-kappa B Kinase | 2 | 2021 | 55 | 0.060 |
Why?
| | Mice, Obese | 1 | 2025 | 66 | 0.060 |
Why?
| | Enzyme Inhibitors | 3 | 2004 | 840 | 0.060 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 162 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2008 | 375 | 0.060 |
Why?
| | Insulin | 1 | 2016 | 2409 | 0.060 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2025 | 46 | 0.060 |
Why?
| | Femur Neck | 1 | 2025 | 61 | 0.060 |
Why?
| | Radiation Tolerance | 1 | 2005 | 96 | 0.060 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 500 | 0.060 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 77 | 0.060 |
Why?
| | Probiotics | 1 | 2025 | 54 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2011 | 1164 | 0.060 |
Why?
| | Adrenergic alpha-Antagonists | 2 | 2002 | 36 | 0.060 |
Why?
| | Bone Diseases, Metabolic | 1 | 2025 | 63 | 0.060 |
Why?
| | Tibia | 2 | 2005 | 178 | 0.060 |
Why?
| | Environmental Pollutants | 1 | 2007 | 159 | 0.060 |
Why?
| | Absorptiometry, Photon | 1 | 2025 | 259 | 0.060 |
Why?
| | Titanium | 1 | 2005 | 82 | 0.060 |
Why?
| | Phenylalanine | 2 | 2001 | 68 | 0.050 |
Why?
| | Activin Receptors, Type I | 1 | 2003 | 8 | 0.050 |
Why?
| | Receptors, Growth Factor | 1 | 2003 | 55 | 0.050 |
Why?
| | DNA Primers | 3 | 2013 | 515 | 0.050 |
Why?
| | Epinephrine | 2 | 2001 | 139 | 0.050 |
Why?
| | Lumbar Vertebrae | 1 | 2025 | 246 | 0.050 |
Why?
| | Mesoderm | 1 | 2004 | 144 | 0.050 |
Why?
| | Protein Kinase C | 1 | 2004 | 261 | 0.050 |
Why?
| | Cell Line | 3 | 2012 | 2847 | 0.050 |
Why?
| | Phosphorylation | 4 | 2010 | 1759 | 0.050 |
Why?
| | Prospective Studies | 2 | 2025 | 7604 | 0.050 |
Why?
| | Cell Culture Techniques | 2 | 2022 | 363 | 0.050 |
Why?
| | Bucladesine | 1 | 2002 | 26 | 0.050 |
Why?
| | Transcription, Genetic | 5 | 2008 | 1457 | 0.050 |
Why?
| | Annexin A5 | 1 | 2002 | 25 | 0.050 |
Why?
| | Peptide Library | 1 | 2002 | 92 | 0.050 |
Why?
| | Nitrates | 1 | 2002 | 92 | 0.050 |
Why?
| | Carrier Proteins | 2 | 2005 | 771 | 0.050 |
Why?
| | Hypertrophy | 1 | 2002 | 133 | 0.050 |
Why?
| | Extracellular Space | 1 | 2002 | 119 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1396 | 0.050 |
Why?
| | Dihydropyridines | 2 | 2001 | 15 | 0.050 |
Why?
| | Gestational Age | 1 | 2005 | 910 | 0.050 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 1 | 2001 | 17 | 0.040 |
Why?
| | COS Cells | 2 | 2000 | 188 | 0.040 |
Why?
| | Paroxetine | 1 | 2021 | 11 | 0.040 |
Why?
| | G-Protein-Coupled Receptor Kinase 2 | 1 | 2021 | 9 | 0.040 |
Why?
| | Conserved Sequence | 2 | 2001 | 239 | 0.040 |
Why?
| | Models, Animal | 2 | 2013 | 384 | 0.040 |
Why?
| | Heart Septum | 1 | 2001 | 28 | 0.040 |
Why?
| | Phenylephrine | 1 | 2001 | 75 | 0.040 |
Why?
| | Mole Rats | 1 | 2020 | 4 | 0.040 |
Why?
| | Organ Culture Techniques | 1 | 2001 | 156 | 0.040 |
Why?
| | Amino Acid Sequence | 3 | 2001 | 2139 | 0.040 |
Why?
| | Bradycardia | 1 | 2001 | 55 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 1993 | 0.040 |
Why?
| | Substantia Nigra | 1 | 2000 | 57 | 0.040 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2000 | 28 | 0.040 |
Why?
| | Cloning, Organism | 1 | 1999 | 6 | 0.040 |
Why?
| | Norepinephrine | 1 | 2001 | 204 | 0.040 |
Why?
| | Imidazoles | 1 | 2001 | 238 | 0.040 |
Why?
| | Blood Glucose | 3 | 2015 | 2186 | 0.040 |
Why?
| | Complement Activation | 1 | 2023 | 415 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1999 | 155 | 0.040 |
Why?
| | Spleen | 2 | 2015 | 514 | 0.040 |
Why?
| | Transfection | 3 | 2009 | 945 | 0.040 |
Why?
| | 3T3 Cells | 1 | 1999 | 163 | 0.040 |
Why?
| | Fibroblasts | 1 | 2005 | 996 | 0.040 |
Why?
| | Femoral Artery | 1 | 2001 | 179 | 0.040 |
Why?
| | Solutions | 1 | 2000 | 168 | 0.040 |
Why?
| | Osteochondrodysplasias | 1 | 2019 | 18 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor Receptor-3 | 1 | 2019 | 7 | 0.040 |
Why?
| | Genes, Reporter | 1 | 1999 | 269 | 0.040 |
Why?
| | Lymphangiogenesis | 1 | 2019 | 27 | 0.040 |
Why?
| | Aged | 3 | 2025 | 23961 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 1999 | 226 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2000 | 534 | 0.040 |
Why?
| | Gene Deletion | 2 | 2013 | 391 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2002 | 596 | 0.040 |
Why?
| | Models, Biological | 4 | 2010 | 1783 | 0.040 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2019 | 59 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2014 | 430 | 0.040 |
Why?
| | Organ Specificity | 1 | 2019 | 305 | 0.040 |
Why?
| | Hydrocortisone | 1 | 2001 | 322 | 0.040 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 2 | 2010 | 9 | 0.040 |
Why?
| | Immunoglobulin Class Switching | 1 | 2018 | 20 | 0.040 |
Why?
| | Epilepsy | 1 | 2002 | 333 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 2019 | 106 | 0.040 |
Why?
| | Sodium-Hydrogen Exchangers | 1 | 1998 | 24 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2019 | 239 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2015 | 3715 | 0.040 |
Why?
| | Cytidine Deaminase | 1 | 2018 | 61 | 0.040 |
Why?
| | Echocardiography | 1 | 2001 | 642 | 0.040 |
Why?
| | Isoproterenol | 1 | 1998 | 113 | 0.030 |
Why?
| | Cytosol | 2 | 2005 | 226 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2025 | 3556 | 0.030 |
Why?
| | Receptors, Prostaglandin E, EP4 Subtype | 2 | 2009 | 5 | 0.030 |
Why?
| | GTP-Binding Proteins | 1 | 1998 | 161 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2000 | 433 | 0.030 |
Why?
| | Ion Transport | 1 | 1997 | 60 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1998 | 385 | 0.030 |
Why?
| | Myelin P0 Protein | 1 | 2017 | 7 | 0.030 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 134 | 0.030 |
Why?
| | Intermediate Filaments | 1 | 2017 | 28 | 0.030 |
Why?
| | Seizures | 1 | 2000 | 426 | 0.030 |
Why?
| | Muscle, Smooth, Vascular | 1 | 1999 | 446 | 0.030 |
Why?
| | Cadmium | 1 | 1997 | 69 | 0.030 |
Why?
| | Middle Aged | 3 | 2025 | 33479 | 0.030 |
Why?
| | Heart Rate | 1 | 2001 | 822 | 0.030 |
Why?
| | Body Mass Index | 1 | 2025 | 2389 | 0.030 |
Why?
| | Potassium | 1 | 1997 | 147 | 0.030 |
Why?
| | Sternum | 2 | 2009 | 24 | 0.030 |
Why?
| | Abscess | 1 | 2017 | 75 | 0.030 |
Why?
| | Kinetics | 2 | 1998 | 1670 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1998 | 560 | 0.030 |
Why?
| | Membrane Potentials | 1 | 1997 | 284 | 0.030 |
Why?
| | Antibodies, Bacterial | 1 | 2017 | 146 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 2017 | 443 | 0.030 |
Why?
| | Fibrinogen | 1 | 2017 | 168 | 0.030 |
Why?
| | Calcium Channel Blockers | 1 | 1997 | 167 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 1995 | 1092 | 0.030 |
Why?
| | Cell Separation | 2 | 2015 | 318 | 0.030 |
Why?
| | Antibodies, Neutralizing | 1 | 2019 | 286 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2010 | 283 | 0.030 |
Why?
| | Virulence | 1 | 2017 | 267 | 0.030 |
Why?
| | Epiphyses | 1 | 2016 | 25 | 0.030 |
Why?
| | Receptor, IGF Type 2 | 1 | 1995 | 6 | 0.030 |
Why?
| | Caspase 3 | 2 | 2008 | 246 | 0.030 |
Why?
| | DNA | 1 | 2002 | 1459 | 0.030 |
Why?
| | Luciferases | 2 | 2005 | 150 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2010 | 545 | 0.030 |
Why?
| | Leukocyte Common Antigens | 1 | 2015 | 87 | 0.030 |
Why?
| | Parkinson Disease | 1 | 2000 | 493 | 0.030 |
Why?
| | Oximes | 1 | 2014 | 24 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 452 | 0.030 |
Why?
| | Shoulder Joint | 1 | 2016 | 173 | 0.030 |
Why?
| | Smad6 Protein | 2 | 2004 | 2 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2016 | 192 | 0.030 |
Why?
| | Calcification, Physiologic | 2 | 2010 | 32 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2015 | 165 | 0.030 |
Why?
| | Tumor Cells, Cultured | 2 | 2005 | 955 | 0.030 |
Why?
| | Blood Pressure | 1 | 2001 | 1786 | 0.030 |
Why?
| | STAT3 Transcription Factor | 1 | 2015 | 206 | 0.030 |
Why?
| | In Situ Hybridization | 2 | 2004 | 316 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 2 | 2009 | 665 | 0.030 |
Why?
| | Adipocytes | 1 | 2015 | 222 | 0.030 |
Why?
| | Age Factors | 1 | 2000 | 3295 | 0.030 |
Why?
| | Receptors, Transforming Growth Factor beta | 2 | 2003 | 59 | 0.030 |
Why?
| | Kidney | 1 | 2001 | 1468 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 861 | 0.020 |
Why?
| | Protein Binding | 2 | 2013 | 2224 | 0.020 |
Why?
| | ADAMTS5 Protein | 1 | 2012 | 4 | 0.020 |
Why?
| | Hydrodynamics | 1 | 2012 | 45 | 0.020 |
Why?
| | Bioreactors | 1 | 2012 | 42 | 0.020 |
Why?
| | Toxicity Tests, Acute | 1 | 2012 | 8 | 0.020 |
Why?
| | Glycoproteins | 1 | 2014 | 342 | 0.020 |
Why?
| | ADAM Proteins | 1 | 2012 | 61 | 0.020 |
Why?
| | Leptin | 1 | 2013 | 236 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2003 | 2129 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 416 | 0.020 |
Why?
| | Fasting | 1 | 2013 | 281 | 0.020 |
Why?
| | Mitochondria, Liver | 1 | 1991 | 73 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2014 | 620 | 0.020 |
Why?
| | Indoles | 1 | 2014 | 412 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2015 | 1178 | 0.020 |
Why?
| | Cell Surface Extensions | 1 | 2010 | 13 | 0.020 |
Why?
| | Phospholipase C gamma | 1 | 2010 | 29 | 0.020 |
Why?
| | Implants, Experimental | 1 | 2010 | 21 | 0.020 |
Why?
| | Compressive Strength | 1 | 2010 | 74 | 0.020 |
Why?
| | Sodium | 1 | 1991 | 217 | 0.020 |
Why?
| | Porosity | 1 | 2010 | 102 | 0.020 |
Why?
| | Transcription Factor HES-1 | 1 | 2010 | 5 | 0.020 |
Why?
| | Cricetinae | 2 | 2001 | 289 | 0.020 |
Why?
| | Trabecular Meshwork | 1 | 2011 | 79 | 0.020 |
Why?
| | Gene Expression Profiling | 2 | 2011 | 1774 | 0.020 |
Why?
| | Polyesters | 1 | 2010 | 76 | 0.020 |
Why?
| | Swine | 1 | 2012 | 775 | 0.020 |
Why?
| | Fibrosis | 1 | 2013 | 552 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2010 | 92 | 0.020 |
Why?
| | Cell Line, Tumor | 2 | 2008 | 3412 | 0.020 |
Why?
| | Surface Properties | 1 | 2010 | 413 | 0.020 |
Why?
| | Structure-Activity Relationship | 2 | 2001 | 570 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2016 | 10811 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 72 | 0.020 |
Why?
| | Materials Testing | 1 | 2010 | 356 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2010 | 402 | 0.020 |
Why?
| | Biomarkers | 2 | 2015 | 4149 | 0.020 |
Why?
| | Collagen Type IX | 1 | 2008 | 1 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 243 | 0.020 |
Why?
| | Wings, Animal | 1 | 2008 | 34 | 0.020 |
Why?
| | Tamoxifen | 1 | 2009 | 202 | 0.020 |
Why?
| | Axin Protein | 1 | 2007 | 19 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2010 | 1272 | 0.020 |
Why?
| | Cholecalciferol | 1 | 2008 | 60 | 0.020 |
Why?
| | Response Elements | 1 | 2008 | 91 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2016 | 1208 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2010 | 1236 | 0.020 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2007 | 31 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 1353 | 0.020 |
Why?
| | Protein Transport | 1 | 2009 | 445 | 0.020 |
Why?
| | Lead Poisoning | 1 | 2007 | 19 | 0.020 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 1 | 2007 | 29 | 0.020 |
Why?
| | Metals, Heavy | 1 | 2007 | 31 | 0.020 |
Why?
| | Vitamins | 1 | 2008 | 185 | 0.020 |
Why?
| | Radiography | 1 | 2009 | 822 | 0.020 |
Why?
| | Transducin | 1 | 2006 | 42 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2010 | 506 | 0.020 |
Why?
| | Adult | 2 | 2025 | 37929 | 0.020 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2005 | 54 | 0.020 |
Why?
| | Caspase 9 | 1 | 2005 | 57 | 0.020 |
Why?
| | Cytochromes c | 1 | 2005 | 60 | 0.020 |
Why?
| | Antigens, Differentiation | 1 | 2005 | 83 | 0.020 |
Why?
| | TCF Transcription Factors | 1 | 2005 | 17 | 0.020 |
Why?
| | Transcription Factor 7-Like 2 Protein | 1 | 2005 | 26 | 0.010 |
Why?
| | Hydrogels | 1 | 2012 | 678 | 0.010 |
Why?
| | I-kappa B Proteins | 1 | 2005 | 81 | 0.010 |
Why?
| | Adenoviridae | 1 | 2006 | 193 | 0.010 |
Why?
| | Joint Capsule | 1 | 2005 | 10 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2005 | 155 | 0.010 |
Why?
| | Cartilage Diseases | 1 | 2005 | 39 | 0.010 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 39 | 0.010 |
Why?
| | Collagenases | 1 | 2004 | 25 | 0.010 |
Why?
| | Caspases | 1 | 2005 | 247 | 0.010 |
Why?
| | Cell Count | 1 | 2005 | 324 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 2004 | 79 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2005 | 232 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2016 | 7635 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2004 | 185 | 0.010 |
Why?
| | Skull | 1 | 2005 | 139 | 0.010 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2003 | 10 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2004 | 86 | 0.010 |
Why?
| | Receptor Cross-Talk | 1 | 2003 | 21 | 0.010 |
Why?
| | Smad5 Protein | 1 | 2003 | 8 | 0.010 |
Why?
| | Morphogenesis | 1 | 2004 | 166 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2004 | 283 | 0.010 |
Why?
| | Genes, src | 1 | 2003 | 5 | 0.010 |
Why?
| | Cytokine Receptor gp130 | 1 | 2003 | 12 | 0.010 |
Why?
| | Mice, Inbred CBA | 1 | 2003 | 54 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 272 | 0.010 |
Why?
| | Synucleins | 1 | 2002 | 7 | 0.010 |
Why?
| | Eukaryotic Initiation Factor-3 | 1 | 2002 | 4 | 0.010 |
Why?
| | Tartrate-Resistant Acid Phosphatase | 1 | 2002 | 5 | 0.010 |
Why?
| | Bacteriophage T7 | 1 | 2002 | 5 | 0.010 |
Why?
| | Multiple System Atrophy | 1 | 2002 | 6 | 0.010 |
Why?
| | Acid Phosphatase | 1 | 2002 | 20 | 0.010 |
Why?
| | Videotape Recording | 1 | 2002 | 35 | 0.010 |
Why?
| | Inclusion Bodies | 1 | 2002 | 28 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2002 | 59 | 0.010 |
Why?
| | Smad4 Protein | 1 | 2002 | 38 | 0.010 |
Why?
| | alpha-Synuclein | 1 | 2002 | 35 | 0.010 |
Why?
| | Animals, Genetically Modified | 1 | 2003 | 240 | 0.010 |
Why?
| | Drug Synergism | 1 | 2003 | 382 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2002 | 229 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 313 | 0.010 |
Why?
| | Isoenzymes | 1 | 2002 | 304 | 0.010 |
Why?
| | Down-Regulation | 1 | 2004 | 657 | 0.010 |
Why?
| | Cellular Senescence | 1 | 2003 | 189 | 0.010 |
Why?
| | Oxymetazoline | 1 | 2001 | 1 | 0.010 |
Why?
| | Dioxanes | 1 | 2001 | 10 | 0.010 |
Why?
| | Clonidine | 1 | 2001 | 28 | 0.010 |
Why?
| | Cerebellum | 1 | 2002 | 224 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 767 | 0.010 |
Why?
| | Oligodendroglia | 1 | 2002 | 179 | 0.010 |
Why?
| | Ephedrine | 1 | 2000 | 4 | 0.010 |
Why?
| | Inositol Phosphates | 1 | 2000 | 22 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2001 | 374 | 0.010 |
Why?
| | Spinal Cord | 1 | 2002 | 370 | 0.010 |
Why?
| | Electroencephalography | 1 | 2002 | 423 | 0.010 |
Why?
| | Antigens, CD | 1 | 2003 | 521 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2000 | 343 | 0.010 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 434 | 0.010 |
Why?
| | Piperazines | 1 | 2001 | 350 | 0.010 |
Why?
| | Models, Chemical | 1 | 2000 | 263 | 0.010 |
Why?
| | Survival Rate | 1 | 2002 | 1972 | 0.010 |
Why?
| | Motor Activity | 1 | 2002 | 718 | 0.010 |
Why?
| | Protein Conformation | 1 | 2000 | 934 | 0.010 |
Why?
| | Stimulation, Chemical | 1 | 1995 | 59 | 0.010 |
Why?
| | Models, Molecular | 1 | 2001 | 1570 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1995 | 201 | 0.010 |
Why?
| | Neurons | 1 | 2002 | 1590 | 0.010 |
Why?
| | Calorimetry | 1 | 1991 | 70 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 362 | 0.010 |
Why?
| | Pregnancy | 1 | 2004 | 6763 | 0.010 |
Why?
| | Fura-2 | 1 | 1990 | 12 | 0.010 |
Why?
| | Cell Fractionation | 1 | 1990 | 56 | 0.010 |
Why?
| | Brain | 1 | 2002 | 2668 | 0.010 |
Why?
| | Organelles | 1 | 1990 | 58 | 0.010 |
Why?
|
|
Zuscik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|